secwatch / observer
8-K filed November 10, 2022, 6:59 PM ET ticker BIVI CIK 0001580149
other material confidence high sentiment neutral materiality 0.00

BioVie shareholders elect all 8 director nominees and ratify auditors at 2022 annual meeting

BIOVIE INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOVIE INC. shareholders approved Election of Directors at the 2022-11-09 meeting.

Proposal
director election
Outcome
passed
Meeting
2022-11-09
Exact text from the filing
Stockholders elected all of the Company’s nominees for director for one-year terms expiring at the next annual meeting of stockholders upon election and qualification of their successors. The voting results were as follows: For Withhold Broker Non-Vote (1) TERREN S. PEIZER 23,780,558 184,068 1,760,515 (2) CUONG DO 23,916,874 37,752 1,760,515 (3) JIM LANG 23,889,937 74,689 1,760,515 (4) MICHAEL SHERMAN 23,917,129 37,497 1,760,515 (5) RICHARD J. BERMAN 23,832,311 132,315 1,760,515 (6) STEVE GORLIN 23,917,129 37,501 1,760,515 (7) ROBERT HARIRI, M.D. PHD 23,878,804 85,822 1,760,515 (8) SIGMUND ROGICH 23,923,084 41,542 1,760,515
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOVIE INC. shareholders approved Approval and Ratification of Auditors at the 2022-11-09 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2022-11-09
Exact text from the filing
Stockholders approved and ratified the appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the 2023 fiscal year. The voting results were as follows: For Against Abstain Broker Non-Vote 25,617,605 94,990 12,546 1,760,515
View on SEC.gov

Browse all shareholder votes →

BIOVIE INC. filing history →

Source: SEC EDGAR
accession 0001520138-22-000509
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.